Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Rifamycin S | HCID 6436726 | — |
| Solvent | [(9E,19E,21Z)-2,15,17,29-tetrahydroxy-27-[2-(4-iodoanilino)-2-oxoethoxy]-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate | HCID 6507126 | — |
| Product | Rifamycin | HCID 6324616 | — |
Reaction Steps
Reaction--Ten grams of the enzyme adsorbed on celite were added to 300 ml of 1% rifamycin B solution (10 mM phosphate buffer, pH 8.5). The conversion to rifamycin S was completed in 7 hours of reaction at 40° C. with aeration and agitation. The celite filter cake recovered by filtration on a sintered glass was washed with 200 ml of methanol. The final methanolic aqueous solution of rifamycin S was warmed to 50° C. in order to solubilize completely the residual rifamycin S precipitate. 30 ml of 5% ascorbic acid solution in water was added thereto dropwisely while continuous stirring. The purpose color of rifamycin S was gradually changed to the deep red color of rifamycin SV. After adjusting the final pH to 4.0, the methanol was completely evaporated using suction evaporator at 40° C. Afte chilling the final solution at 4° C. for 2 days, the rifamycin SV crystals were recovered by filtration. 2.4 gr of deep yellowish rifamycin SV crystals were obtained after drying over sodium sulfate (yield=87%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04431735 |
|---|
| Source dataset | uspto-grants-1984_02 |
|---|
| ORD ID | ord-835ab6c1bbac4370bf72cee22524c5c0 |
|---|
| Source note | uspto-grants-1984_02 |
|---|